What is Jessica Haraga's NPI number?

Jessica Haraga's National Provider Identifier (NPI) is 1023556404, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Jessica Haraga's specialty?

Jessica Haraga is listed in the NPPES registry with a primary specialty of Gastroenterology Physician (Allopathic & Osteopathic Physicians).

Where is Jessica Haraga located?

Jessica Haraga's practice location on file with NPPES is 19250 Sw 90th Ave, Tualatin, OR 97062-7585.

What is Jessica Haraga's phone number?

The practice phone number listed in the NPPES registry for Jessica Haraga is (503) 692-3750.

Does Jessica Haraga accept Medicare?

Jessica Haraga is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Jessica Haraga's NPI active?

Yes — Jessica Haraga's NPI (1023556404) is active in the NPPES registry as of the last update on 2023-11-28.

IndividualActiveAccepts Medicare

Jessica Haraga, MD

NPI 1023556404 · Gastroenterology Physician · Tualatin, OR

Jessica Haraga, MD is a Gastroenterology Physician provider in Tualatin, OR (NPI 1023556404).

Provider details

NPI number: 1023556404
Entity type: Individual
Primary specialty: Gastroenterology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: MD191837 (OR)

Practice location

19250 Sw 90th Ave

Tualatin, OR 97062-7585

Phone: (503) 692-3750

Fax: (503) 691-2324

Street-level locationGet directions

More OR providers

Mailing address

541 Ne 20th Ave Ste 225

Portland, OR 97232-2895

Specialties & taxonomies

Gastroenterology PhysicianPrimary207RG0100XLicense MD191837 (OR)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

1508 Division St Ste 15
Oregon City, OR 97045-1583
Phone: (503) 692-3750
Fax: (503) 691-2324

Enrolled with Medicare as Practitioner - Gastroenterology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(63/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
9 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
234 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	68	$40
Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222	34	$127
Removal of Polyps Or Growths of Large Bowel Using an Endoscope With Mechanical Snare45385	31	$247
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	26	$77
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	25	$130
Biopsy of Esophagus, Stomach, And/Or Upper Small Bowel Using a Flexible Endoscope

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Omeprazole	29	16
Sodium, Potassium,mag Sulfatesbrand: Sod Sulf-Potass Sulf-Mag Sulf	24	24
Peg3350/Sod Sulf,bicarb,cl/Kclbrand: Gavilyte-G	24	24
Ondansetron Hcl	19	18
Pantoprazole Sodium	17	—
Budesonidebrand: Budesonide Dr	12	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$32 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2017-02-07
Last updated: 2023-11-28
Certified: 2023-11-28

Frequently asked questions

What is Jessica Haraga's NPI number?: Jessica Haraga's National Provider Identifier (NPI) is 1023556404, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Jessica Haraga's specialty?: Jessica Haraga is listed in the NPPES registry with a primary specialty of Gastroenterology Physician (Allopathic & Osteopathic Physicians).
Where is Jessica Haraga located?: Jessica Haraga's practice location on file with NPPES is 19250 Sw 90th Ave, Tualatin, OR 97062-7585.
What is Jessica Haraga's phone number?: The practice phone number listed in the NPPES registry for Jessica Haraga is (503) 692-3750.
Does Jessica Haraga accept Medicare?: Jessica Haraga is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Jessica Haraga's NPI active?: Yes — Jessica Haraga's NPI (1023556404) is active in the NPPES registry as of the last update on 2023-11-28.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	68	$40
Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222	34	$127
Removal of Polyps Or Growths of Large Bowel Using an Endoscope With Mechanical Snare45385	31	$247
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	26	$77
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	25	$130
Biopsy of Esophagus, Stomach, And/Or Upper Small Bowel Using a Flexible Endoscope

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Omeprazole	29	16
Sodium, Potassium,mag Sulfatesbrand: Sod Sulf-Potass Sulf-Mag Sulf	24	24
Peg3350/Sod Sulf,bicarb,cl/Kclbrand: Gavilyte-G	24	24
Ondansetron Hcl	19	18
Pantoprazole Sodium	17	—
Budesonidebrand: Budesonide Dr	12	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$32 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments